Pancreatic cancer (PC, mostly pancreatic ductal adenocarcinoma, PDAC) is one of the deadliest cancers, with a median survival of less than 1 year and a 5-year survival of only about 10%. 80% of patients with PDAC are inoperable at diagnosis, and there is no curative treatment for advanced PDAC. Learn more：small molecule drug development for PC